Agreed. The FDA trials are what have kept me here. If this
Agreed. The FDA trials are what have kept me here. If this was a tech company or a pre-clinical I would have been out long ago as the goal posts kept moving, milestones were missed, and funding deteriorated. My faith in the competency of management to state goals and meet them on time took a serious hit over the past year.
The progress in clinical FDA trials cannot be faked though. FDA trials + a real injection of cash (not the shoe string funding BS but $50M+) will jump start this company.
As for their interest in a $0.14 biotech with minimal funding options? Well, you can make 100% no matter where you start shorting from. They are vultures and believe we are barely breathing soon-to-be carrion if this deal doesn't come through. With the track record over the past year or two, betting against the EoP2 meeting doesn't seem like all that much of a long shot.
Let's see what they say. I'm all in holding more shares than I would like. Not a sign of confidence but more that most of the value is already gone so I might as well hold for a comeback. Buyer beware. Seller beware x2.
Go IPIX!
3
Innovation Pharmaceuticals Inc (IPIX) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Award-Winning Green Healthcare from NUH The National University Hospital (NUH) in Singapore is making waves and cleaning the air at the same time. It's racked up a shiny Gold Award at the 2026 International Hospital Federation (IHF) Awards for its Green Operating Theatre programme — and folks, it's not just any old clap on the back. This is low-carbon healthcare in...
Continue Reading
Cesar Alvarez's Legacy Honored in Miami The Greater Miami Chamber of Commerce's 2026 Sand in My Shoes® Award has found its latest recipient in Cesar L. Alvarez, the Senior Chairman of Greenberg Traurig, P.A. It wasn't just a ceremony—this was a gathering of more than 800 of Miami's business and community power players on October 15, 2026. And man, did it shine a bright...
Continue Reading
What Went Wrong with Unicycive? Unicycive Therapeutics, Inc., a player in the biotech space, finds itself embroiled in a legal quagmire. A class action lawsuit is hovering over NASDAQ:UNCY, spurred by allegations of the company's slip-ups in manufacturing oversight. Investors are ticked off, understandably, as the lawsuit zeroes in on failures to resolve FDA-cited issues....
Continue Reading
AI Drives Evolution in Network Infrastructure Look, the world of networking won't sit still, and Supermicro proves it's got skin in the game by bringing AI right to the network's edge. This time, they're hob-nobbing with Nokia and NVIDIA to see what AI-RAN can really do. If this feels like a sneak peek into the future, well, that’s because it is. These guys are blending...
Continue Reading
Tides Are Shifting: Skanska's Ambitious NYC Endeavor In the bustling concrete jungle of New York City, the skyline's getting a fresh addition, but this time, it's down by the water. Skanska's snagged a handsome USD 163 million deal with New York City's own Department of Design and Construction, promising a complete transformation of a stretch along the East River....
Continue Reading
The Evolving Landscape of Luxury Travel Time, it seems, is the new currency in the realm of luxury travel. Forget plush hotel suites or exclusive first-class cabins—the new game is all about maximizing your moments at the destination rather than en route. 2026 showed us vivid snapshots of this trend, courtesy of SELECT Private Jets by Internova, revealing how...
Continue Reading
Ever notice how the arts can cut through the noise and spotlight voices we often overlook? Well, that's exactly what's happening at the Hawai?i International Film Festival (HIFF) this year. The Vilcek Foundation, alongside HIFF, is bringing the New American Perspectives program back for another round at the festival’s 46th edition, and it's a heck of a lineup....
Continue Reading
Teaching Kids to Catch Themselves: Introducing BEFORE Calling October Bullying Prevention Month seems quaint when you consider how often kids get shoved around, physically or emotionally. What’s surprising is how one simple word, ‘BEFORE,’ might just be the game-changer. Dr. Anke Otto-Wolf is betting big on it by unveiling the BEFORE Framework™. Imagine kids...
Continue Reading
Revamp in Emergency Training for School Incidents No longer can schools afford the luxury of uncoordinated chaos during emergencies. Today, the firepower behind the National Center for Integrated Emergency Response (NCIER) comes from the realization that courage alone doesn't cut it. It's about time someone put the pieces together, getting cops, fire, school staff, and...
Continue Reading
Spotlight on AWS and 3M’s Partnership Forget the old guard—tech titans are syncing up and 3M's Expanded Beam Optical (EBO) platform is the new belle of the ball. Amazon Web Services (AWS) has opened its checkbook to seriously scale this cutting-edge technology within its data centers. A Quantum Leap In Connectivity Honestly, if we’re gonna talk about what makes a...
Continue Reading
eading: Cystic Fibrosis Market: Emerging Therapies Boost Growth">
Continue Reading